Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Capital Employed (2016 - 2026)

Catalyst Pharmaceuticals filings provide 16 years of Return on Capital Employed readings, the most recent being 26.94% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 316.0% to 26.94% in Q1 2026 year-over-year; TTM through Mar 2026 was 26.94%, a 316.0% decrease, with the full-year FY2025 number at 31.04%, down 509.0% from a year prior.
  • Return on Capital Employed hit 26.94% in Q1 2026 for Catalyst Pharmaceuticals, down from 27.7% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 37.05% in Q2 2023 to a low of 14.7% in Q2 2024.
  • Median Return on Capital Employed over the past 5 years was 28.24% (2024), compared with a mean of 27.81%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -2235bps in 2024 and later soared 1472bps in 2025.
  • Catalyst Pharmaceuticals' Return on Capital Employed stood at 34.31% in 2022, then crashed by -31bps to 23.75% in 2023, then grew by 19bps to 28.24% in 2024, then dropped by -2bps to 27.7% in 2025, then dropped by -3bps to 26.94% in 2026.
  • The last three reported values for Return on Capital Employed were 26.94% (Q1 2026), 27.7% (Q4 2025), and 29.31% (Q3 2025) per Business Quant data.